RCORP Corner


Welcome to the RCORP Corner! This page will house the various RCORP articles and blog posts, including the RCORP-TA Newsletter. You can find the various features below. Questions? Email trabolt@jbsinternational.com.

RCORP-TA Newsletter

The monthly newsletter highlights the various features below as well as resources, events, funding opportunities, and more!

Download the latest RCORP-TA Newsletter

View RCORP-TA Newsletter past issues


Guest writers and special blog posts will be regularly featured here in the RCORP Blog.
Thank you to the dozens of RCORP grantees who submitted to the 2022 "Power of RCORP" Photo Showcase! Click the title to see the

Staff Spotlight

Our new staff spotlights are a way for RCORP stakeholders to learn a bit more about the staff behind the scenes at JBS and HRSA.

Content Hubs

Content Hubs will house in-depth tools and resources for a variety of RCORP topic categories.
Xylazine, also referred to as “tranq,” is a non-opioid veterinary tranquilizer increasingly associated with overdose deaths in the United States. It is a central nervous system depressant and can cause respiratory depression. When used in combination with opioids such as fentanyl, it can have a synergistic effect and increase risk of overdose.